Life Science Firms are Turning to Firmex to do De...( Life science...)

Life science firms have to follow a rigorous documentation process to comply with a host of FDA regulations. As a result, when entering into various corporate agreements these firms are faced with the daunting task of sharing thousands of confidential documents. Firmex provides life science firms with an affordable unlimited use facility to share thousands of confidential documents securely and indefinitely. Typical uses are corporate finance, partnering, M&A and executive reporting.

(PRWEB) September 21, 2009 -- Life science firms have to follow a rigorous documentation process to comply with a host of FDA regulations. As a result, when entering into various corporate agreements these firms are faced with the daunting task of sharing hundreds if not thousands of confidential documents. "We have more customers in life sciences than any other corporate vertical. They have a far more document intensive business than other industries and are frequently engaged in transactions" says Joel Lessem, Firmex CEO. The Firmex product is licensed by life science firms to manage confidential document sharing processes on an unlimited use basis. Firmex's flat fee subscription pricing based on internal users accommodates small, medium and large global organizations. Since approximately 82% of the industry's firms have fewer than fifty employees, having an offering that is affordable to smaller companies is essential. Further as a hosted solution, there are no IT costs or implementation fees. Firmex provides world-class security and data back-up as part of the subscription.

Common uses of Firmex for life science firms are:

1. Multiple Rounds of Equity Financing
Since most firms are in the development stage, they are almost entirely dependent on investor capital. As a result, the majority of life science firms are either raising capital or preparing to raise capital on a continu
'/>"/>